.Zevra Therapeutics' unusual health condition medicine seems to become on the course to authorizatio...
.Pfizer's phase 3 Duchenne muscular dystrophy (DMD) gene treatment failing has blown a $230 thousand...
.After more than twenty years of work with neurodegenerative conditions, Swiss biotech AC Immune cla...
.GSK has ditched a phase 2 human papillomavirus (HPV) injection from its pipeline after making a dec...
.Operating system Therapies will certainly specify on the NYSE American inventory substitution today...
.ALX Oncology's stage 2 gastric cancer action price has actually deteriorated. After viewing its CD4...
.An Additional of Ionis Pharmaceuticals' essential midphase readouts has actually disappointed requi...
.While Biogen's pharma peers are hunting for late-stage resources along with little risk, CEO Chris ...
.Instil Bio has been actually a biotech trying to find a pipeline after it ditched its lead assets o...
.Biogen has handed back civil liberties to an early Alzheimer's health condition plan to Denali Reha...